Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13234
Country/Region: Vietnam
Year: 2017
Main Partner: KNCV Tuberculosis Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $438,852

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,913
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 128
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 63
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 159
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 490
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 1,201
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 27
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 101
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 7
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 22
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 52
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 93
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 84
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 8
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 24
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 58
TB_PREV By Age/Sex (Numerator): <15, Female 2018 22
TB_PREV By Age/Sex (Numerator): <15, Male 2018 13
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 584
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,109
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 1,728
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,161
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 24
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 20
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 726
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,391
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 67
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 168
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 518
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,272
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,025
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,250
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 74
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 187
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 575
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,414
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 24,790
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 567
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 4
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 3
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 187
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 373
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 307
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 250
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 8,367
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 15,866